Skip to main content
. 2021 Nov 17;26(22):6923. doi: 10.3390/molecules26226923

Figure 3.

Figure 3

Effects of quercetin (Q) and the quercetin-pentaacetate analogue (Q5) on the viability of HepG2 (A,B) and HL-60 (C,D) cells (20, 40 and 80 µM) or doxorubicin (5 µM) as determined by AlamarBlue after 72 h of treatment. Values are represented as the mean ± SD of three independent experiments performed in triplicate. *** p < 0.001 compared to untreated cells.